Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 54

1.

Short Communication: Decreased Plasma Calcitonin Gene-Related Peptide as a Novel Biomarker for HIV-1 Disease Progression.

Bomsel M, Lopalco L, Uberti-Foppa C, Siracusano G, Ganor Y.

AIDS Res Hum Retroviruses. 2019 Jan;35(1):52-55. doi: 10.1089/AID.2018.0210. Epub 2019 Jan 2.

PMID:
30489145
2.

The Abrogation of Phosphorylation Plays a Relevant Role in the CCR5 Signalosome Formation with Natural Antibodies to CCR5.

Venuti A, Pastori C, Siracusano G, Pennisi R, Riva A, Tommasino M, Sciortino MT, Lopalco L.

Viruses. 2017 Dec 28;10(1). pii: E9. doi: 10.3390/v10010009.

3.

The Role of Natural Antibodies to CC Chemokine Receptor 5 in HIV Infection.

Venuti A, Pastori C, Lopalco L.

Front Immunol. 2017 Oct 30;8:1358. doi: 10.3389/fimmu.2017.01358. eCollection 2017. Review.

4.

Induction of Antihuman C-C Chemokine Receptor Type 5 Antibodies by a Bovine Herpesvirus Type-4 Based Vector.

Verna AE, Franceschi V, Tebaldi G, Macchi F, Menozzi V, Pastori C, Lopalco L, Ottonello S, Cavirani S, Donofrio G.

Front Immunol. 2017 Oct 25;8:1402. doi: 10.3389/fimmu.2017.01402. eCollection 2017.

5.

M48U1 and Tenofovir combination synergistically inhibits HIV infection in activated PBMCs and human cervicovaginal histocultures.

Musumeci G, Bon I, Lembo D, Cagno V, Re MC, Signoretto C, Diani E, Lopalco L, Pastori C, Martin L, Ponchel G, Gibellini D, Bouchemal K.

Sci Rep. 2017 Feb 1;7:41018. doi: 10.1038/srep41018.

6.

Class B β-arrestin2-dependent CCR5 signalosome retention with natural antibodies to CCR5.

Venuti A, Pastori C, Pennisi R, Riva A, Sciortino MT, Lopalco L.

Sci Rep. 2016 Dec 23;6:39382. doi: 10.1038/srep39382.

7.

GM-3 Lactone Mimetic Interacts with CD4 and HIV-1 Env Proteins, Hampering HIV-1 Infection without Inducing a Histopathological Alteration.

Richichi B, Pastori C, Gherardi S, Venuti A, Cerreto A, Sanvito F, Toma L, Lopalco L, Nativi C.

ACS Infect Dis. 2016 Aug 12;2(8):564-71. doi: 10.1021/acsinfecdis.6b00056. Epub 2016 Jun 24.

PMID:
27626296
8.

Dysfunctions in the migratory phenotype and properties of circulating immature transitional B cells during HIV-1 infection.

Amu S, Fievez V, Nozza S, Lopalco L, Chiodi F.

AIDS. 2016 Sep 10;30(14):2169-77. doi: 10.1097/QAD.0000000000001182.

PMID:
27281060
9.

High-efficiency antibody discovery achieved with multiplexed microscopy.

Mettler Izquierdo S, Varela S, Park M, Collarini EJ, Lu D, Pramanick S, Rucker J, Lopalco L, Etches R, Harriman W.

Microscopy (Oxf). 2016 Aug;65(4):341-52. doi: 10.1093/jmicro/dfw014. Epub 2016 Apr 21.

10.

ERK1-Based Pathway as a New Selective Mechanism To Modulate CCR5 with Natural Antibodies.

Venuti A, Pastori C, Siracusano G, Riva A, Sciortino MT, Lopalco L.

J Immunol. 2015 Oct 1;195(7):3045-57. doi: 10.4049/jimmunol.1500708. Epub 2015 Aug 31.

11.

Synergy in monoclonal antibody neutralization of HIV-1 pseudoviruses and infectious molecular clones.

Miglietta R, Pastori C, Venuti A, Ochsenbauer C, Lopalco L.

J Transl Med. 2014 Dec 13;12:346. doi: 10.1186/s12967-014-0346-3.

12.

Spontaneous control of HIV-1 viremia in a subject with protective HLA-B plus HLA-C alleles and HLA-C associated single nucleotide polymorphisms.

Moroni M, Ghezzi S, Baroli P, Heltai S, De Battista D, Pensieroso S, Cavarelli M, Dispinseri S, Vanni I, Pastori C, Zerbi P, Tosoni A, Vicenzi E, Nebuloni M, Wong K, Zhao H, McHugh S, Poli G, Lopalco L, Scarlatti G, Biassoni R, Mullins JI, Malnati MS, Alfano M.

J Transl Med. 2014 Dec 5;12:335. doi: 10.1186/s12967-014-0335-6.

13.

Frequency and phenotype of B cell subpopulations in young and aged HIV-1 infected patients receiving ART.

Amu S, Lavy-Shahaf G, Cagigi A, Hejdeman B, Nozza S, Lopalco L, Mehr R, Chiodi F.

Retrovirology. 2014 Sep 11;11:76. doi: 10.1186/s12977-014-0076-x.

14.

Induction of HIV-blocking anti-CCR5 IgA in Peyers's patches without histopathological alterations.

Pastori C, Diomede L, Venuti A, Fisher G, Jarvik J, Bomsel M, Sanvito F, Lopalco L.

J Virol. 2014 Apr;88(7):3623-35. doi: 10.1128/JVI.03663-13. Epub 2014 Jan 8.

15.

Calcitonin gene-related peptide inhibits Langerhans cell-mediated HIV-1 transmission.

Ganor Y, Drillet-Dangeard AS, Lopalco L, Tudor D, Tambussi G, Delongchamps NB, Zerbib M, Bomsel M.

J Exp Med. 2013 Oct 21;210(11):2161-70. doi: 10.1084/jem.20122349. Epub 2013 Sep 30.

16.

Investigational treatment suspension and enhanced cell-mediated immunity at rebound followed by drug-free remission of simian AIDS.

Shytaj IL, Chirullo B, Wagner W, Ferrari MG, Sgarbanti R, Corte AD, LaBranche C, Lopalco L, Palamara AT, Montefiori D, Lewis MG, Garaci E, Savarino A.

Retrovirology. 2013 Jul 16;10:71. doi: 10.1186/1742-4690-10-71.

17.

A nonparametric procedure for defining a new humoral immunologic profile in a pilot study on HIV infected patients.

Brombin C, Diomede L, Tudor D, Drillet AS, Pastori C, Poli E, Riva A, Uberti-Foppa C, Galli M, Di Serio C, Bomsel M, Lopalco L.

PLoS One. 2013;8(3):e58768. doi: 10.1371/journal.pone.0058768. Epub 2013 Mar 22.

18.

Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes.

Leroux-Roels G, Maes C, Clement F, van Engelenburg F, van den Dobbelsteen M, Adler M, Amacker M, Lopalco L, Bomsel M, Chalifour A, Fleury S.

PLoS One. 2013;8(2):e55438. doi: 10.1371/journal.pone.0055438. Epub 2013 Feb 20.

19.

Isotype modulates epitope specificity, affinity, and antiviral activities of anti-HIV-1 human broadly neutralizing 2F5 antibody.

Tudor D, Yu H, Maupetit J, Drillet AS, Bouceba T, Schwartz-Cornil I, Lopalco L, Tuffery P, Bomsel M.

Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12680-5. doi: 10.1073/pnas.1200024109. Epub 2012 Jun 20.

20.

Stable changes in CD4+ T lymphocyte miRNA expression after exposure to HIV-1.

Bignami F, Pilotti E, Bertoncelli L, Ronzi P, Gulli M, Marmiroli N, Magnani G, Pinti M, Lopalco L, Mussini C, Ruotolo R, Galli M, Cossarizza A, Casoli C.

Blood. 2012 Jun 28;119(26):6259-67. doi: 10.1182/blood-2011-09-379503. Epub 2012 Jan 27.

Supplemental Content

Loading ...
Support Center